52-Week Safety and Disease Control With Ruxolitinib Cream in Children Aged 2 to 11 Years With Atopic Dermatitis: Results From the Phase 3 TRuE-AD3 Study
Publication/Presentation Date
Fall 2024
Volume
18
Issue
4
Published In/Presented At
Society of Dermatology Physician Associates Abstracts from the Annual Fall 2024 Dermatology Conference November 13-17, 2024. Journal of Dermatology for Physician Assistants 18(4):p e1-e35, Fall 2024. | DOI: 10.1097/jdpa.0000000000000040
Disciplines
Medicine and Health Sciences
Department(s)
Department of Medicine Faculty
Document Type
Article
COinS
